The Madison, WI-based company said its test can identify metabolic subtypes associated with the Autism Spectrum and can be used to screen children as young as 18 months.
Diagnostics manufacturer OpGen is partnering with ILUM and the NY State Department of Health to detect, track, and manage antimicrobial-resistant infections at healthcare institutions statewide.
A panel of IVD experts will discuss the latest in vitro diagnostic trends at the BIOMEDevice San Jose conference in December.
It's been a full year since Abbott closed its $5.3 billion acquisition of Alere, a deal that almost didn't happen.
Aromyx Corp. announces its groundbreaking biosensor technology based on the human sense of smell and taste. The company says the new technology has the potential to be used as a diagnostic tool to detect early stage cancer and disease.
Quadrant Biosciences scored a $2 million NIH grant to supports its epigenetic diagnostic test for autism spectrum disorder.
Seven key trends and events helped make Liquid Biopsy attractive to investors, shareholders, patients, and physicians.
Audrey Turley, of Nelson Labs, will speak at Medical Design & Manufacturing Minneapolis about biocompatibility issues related to medical devices including the move to more in vitro testing and the 2020 deadline for the new European Medical Device Regulation.
The study looked at nearly 1,048 patients to test the prognostic value of the VeriStrat test in patients with non-small cell lung cancer.
A new diagnostic system with digital imaging capabilities aims to enhance lab capabilities across the globe through multi-test processing, dry slide technology, and a full testing environment for accurate testing in a waterless environment.
FDA has given approval for the Roche’s cobas HPV Test to be used as the first-line screening test for cervical cancer in women 25 and older using cervical specimens collected in SurePath preservative fluid, a collection medium commonly used for Pap tests.
Personal Genome Diagnostics received a breakthrough device designation from FDA for the PGDx elio plasma resolve liquid biopsy test.